Stock ODYY ODYSSEY HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Odyssey Health, Inc.

Equities

ODYY

US67612C1027

Market Closed - OTC Markets
Other stock markets
 11:49:46 28/05/2024 pm IST 		5-day change 1st Jan Change
0.04 USD 0.00% Intraday chart for Odyssey Health, Inc. 0.00% -60.00%
22/03 Odyssey Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024 CI
2023 Oragenics, Inc. completed the acquisition of Assets related to proprietary neurological drug therapies and technologies of Odyssey Health, Inc. CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Odyssey Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024
CI
Oragenics, Inc. completed the acquisition of Assets related to proprietary neurological drug therapies and technologies of Odyssey Health, Inc.
CI
Odyssey Health, Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023
CI
Odyssey Health, Inc. Reports Earnings Results for the Full Year Ended July 31, 2023
CI
Odyssey Health, Inc. Announces the Resignation of John Gandolfo as Director
CI
Oragenics to Acquire Odyssey Health's Neurological Drug Technology Pipeline Including Concussion Drug Candidate
AQ
Oragenics, Inc. entered into an Asset Purchase Agreement to acquire Assets related to proprietary neurological drug therapies and technologies of Odyssey Health, Inc.
CI
Odyssey Health, Inc. Presents Concussion Treatment Data At the Military Health System Research Symposium -MHSRS
CI
AM Best Upgrades Credit Ratings of Odyssey Group Holdings, Inc.'s Members
AQ
Odyssey Health, Inc. executed a non- binding letter of intent to acquire Speranza Therapeutics, Inc.
CI
Odyssey Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023
CI
ODYSSEY HEALTH, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
AQ
Odyssey Health, Inc. Preparing for a Phase II Pharmaceutical Concussion Treatment
AQ
ODYSSEY HEALTH, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
Odyssey Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023
CI
Odyssey Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023
CI
Odyssey Health, Inc. Forms Community-Based Partnership with David R. Metcalf Foundation for Military Concussion Research
AQ
ODYSSEY HEALTH, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
Odyssey Health, Inc. Appoints Jeffrey Conroy as Director
CI
Odyssey Health, Inc. to Develop Intranasal Field- Deliverable Nerve Agent Antidote
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ODYY Stock
  4. News Odyssey Health, Inc.